These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24696529)

  • 21. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
    He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
    Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
    Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM
    Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.
    Strati A; Kasimir-Bauer S; Markou A; Parisi C; Lianidou ES
    Breast Cancer Res; 2013 Mar; 15(2):R20. PubMed ID: 23497487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
    Frolik D; Caduff R; Varga Z
    Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients.
    Radwan WM; Moussa HS; Essa ES; Kandil SH; Kamel AM
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):66-70. PubMed ID: 22897908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of mammaglogin A in blood from breast cancer patients, before and after treatment, using a one-tube nested PCR protocol. Association with the absence of tumor estrogen receptors.
    Ceballos MP; Zumoffen C; Massa E; Cipulli G; Funes CC; Gil AB; Morales C; Tozzini R; Ghersevich S
    Clin Biochem; 2011 Dec; 44(17-18):1429-33. PubMed ID: 21939647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
    Thriveni K; Raju A; Kumar RV; Krishnamurthy S; Chaluvarayaswamy R
    Clin Breast Cancer; 2019 Feb; 19(1):27-34. PubMed ID: 30217473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
    Elfagieh M; Abdalla F; Gliwan A; Boder J; Nichols W; Buhmeida A
    Tumour Biol; 2012 Dec; 33(6):2371-7. PubMed ID: 22948780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S; Bal A; Singh G; Joshi K
    Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication.
    Raval A; Trivedi S
    Indian J Exp Biol; 2016 Oct; 54(10):619-629. PubMed ID: 30084561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.
    Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR
    Breast J; 2003; 9(3):200-7. PubMed ID: 12752628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
    Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
    Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between preoperative serum CA 15-3 and CEA levels and clinicopathological parameters in breast cancer.
    Moazzezy N; Farahany TZ; Oloomi M; Bouzari S
    Asian Pac J Cancer Prev; 2014; 15(4):1685-8. PubMed ID: 24641390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma.
    Sussman LK; Upalakalin JN; Roberts MJ; Kocher O; Benjamin LE
    Cancer Biol Ther; 2003; 2(3):255-6. PubMed ID: 12878859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
    Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum biochemical markers in carcinoma breast.
    Seth LR; Kharb S; Kharb DP
    Indian J Med Sci; 2003 Aug; 57(8):350-4. PubMed ID: 12944692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM; Teama S; Fawzy A; El Deftar M
    Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.